BHCUX Mutual Fund

BHCUX Mutual Fund

NAV$23.49
See how much of BHCUX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
0.85%
Dividend Yield (Current)
-
Holdings
41
Inception Date
Apr 30, 2018
Fund Family
Baron Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Unspecified

Performance

YTD+3.81%
1 Year+24.97%
3 Year+5.49%
5 Year+0.94%

Asset Allocation

Stocks: 100.00%
See how much of BHCUX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.9.95%
AZN:LNAstraZeneca PLC5.09%
JNJJohnson & Johnson - Common4.58%
TMOThermo Fisherscientific Inc.4.25%
MTDMettler-Toledo International Inc.3.99%
Top 10 Concentration: 43.86%Report Date: Mar 31, 2026
Download all 41 holdings for BHCUX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Unspecified
Latest Distribution
$0.22
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

BHCUX Mutual Fund Overview

BHCUX Mutual Fund (Baron Health Care Fund Class R6) is managed by Baron Funds. BHCUX expense ratio is 0.85%, holding 41 positions across sectors including Health Care, Real Estate. Inception date: 2018-04-30.

BHCUX performance shows a YTD return of 3.81%. The 1-year return is 24.97% and the 5-year return is 0.94%.

BHCUX top holdings include Eli Lilly & Co. (9.9%), AstraZeneca PLC (5.1%), Johnson & Johnson - Common (4.6%), Thermo Fisherscientific Inc. (4.3%), Mettler-Toledo International Inc. (4.0%). Go to all BHCUX holdings, BHCUX sectors, or BHCUX dividends.

BHCUX can be compared against other funds. Use BHCUX overlap to find shared positions, or BHCUX vs another fund for a side-by-side view. BHCUX alternatives are available via the screener, along with tax-loss harvesting opportunities.